Aquestive Therapeutics, Inc.
Recent Filings
All 618 filings →| Form | Description | Date |
|---|---|---|
| 8-K | 8-K | Mar 20, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 11, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 11, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 11, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 11, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 11, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 11, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 11, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 11, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 11, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Boyd Peter E. | Chief People Officer | Award / Grant | 20,000 | 288,323 | Dec 4, 2025 |
| Davis Matthew W. | Chief Development Officer | Award / Grant | 50,000 | 50,000 | Nov 10, 2025 |
| Kraus Carl N | Chief Medical Officer | Sale | 20,272 @ $7.00 | 282,475 | Oct 15, 2025 |
| Boyd Peter E. | See Remarks | Sale | 10,000 @ $7.00 | 268,323 | Oct 15, 2025 |
| Barber Daniel | President and CEO | Sale | 91,343 @ $6.03 | 923,430 | Sep 26, 2025 |
| Boyd Peter E. | See Remarks | Sale | 10,000 @ $6.30 | 278,323 | Sep 26, 2025 |
| Barber Daniel | President and CEO | Sale | 400 @ $6.00 | 1,014,773 | Sep 19, 2025 |
| Boyd Peter E. | See Remarks | Sale | 15,000 @ $5.30 | 288,323 | Sep 5, 2025 |
| Korczynski Sherry | Chief Commercial Officer | Award / Grant | 25,000 | 181,858 | Aug 14, 2025 |
| Cioffi Melina | SVP, Regulatory Affairs | Award / Grant | 20,000 | 202,261 | May 15, 2025 |